期刊文献+

利用BglBrick方法进行HSA/Exendin-4长效融合蛋白的快速组装

Rapid Assembly of Long-term HSA /Exendin 4 Fusion Protein via BglBrick Method
原文传递
导出
摘要 目的:通过合成生物学的BglBrick方法快速构建不同种类HSA/Exendin-4长效融合蛋白,为进行各HSA/Exendin-4融合蛋白生物学活性的筛选比较奠定基础。方法:选用酵母表达载体pPICZαA质粒,构建pPICZαA-E4和pPICZαA-HSA两种基础Brick表达载体,运用BglBrick方法,实现了不同数目Exendin-4分子在HSA的不同末端的快速组装。将构建出的10种HSA/Exendin-4融合蛋白,转入毕赤酵母菌KM71H中,用甲醇诱导目的蛋白的表达。结果:用BglBrick方法构建的HSA/Exendin-4融合蛋白在毕赤酵母中都成功诱导表达出相应的目的蛋白。结论:利用BglBrick方法能够实现HSA长效融合蛋白的快速组装。 Objective: Different kinds of HSA/Exendin4 fusion protein are rapidly constructed using BglBrick method of synthetic biology. It lays a foundation for screening and comparison of the bioactivity of fusion protein in each HSA/Exendin-4. Method: Two basic Brick expression vectors, pPICZαA-Exendin4 and pPTCZαA-HSA, are constructed based on the yeast expression vector, pPICZαA plasmid. Rapid assemblies of different amounts of Exendin4 molecules at the terminals of HSA are achieved via BglBrick method. Ten constructed HSA/Exendin-4 fusion proteins are integrated into the chromosome of Pichia pastoris KM71H, and the corresponding target proteins are expressed after methanol induction. Result:The constructed HSA/Exendin-4 fusion proteins via BglBrick method successfully express the corresponding target protein in Pichia pastoris after methanol induction. Conclusion: The use of BglBrick method can help fulfill the rapid assembly of long-term HAS fusion proteins.
出处 《中国生物工程杂志》 CAS CSCD 北大核心 2014年第4期59-64,共6页 China Biotechnology
基金 "十二五"重大新药创制国家科技重大专项资助项目(2012ZX09301003)
关键词 BglBrick EXENDIN-4 HSA融合蛋白 合成生物学 BglBrick Exendin4 HSA fusion protein Synthetic biology
  • 相关文献

参考文献20

  • 1DeFronzo R A, Ratner R E, Han J, et al.Effects of exenatide (exendin- 4) on glycemic control and weightover 30 weeks in metformin - treated patients withtype 2 diabetes. Diabetes Care, 2005, 28(5): 1092.
  • 2Kolterman O G, Buse J B, Fineman M S, et al. Synthetic Exendin-4 (AC2993) significantly reduces postprandial and fasting plasma glucose in subjects with type2 diabetes. J Clin Endocrinal Metab, 2003, 88(7): 3082- 3089.
  • 3De Leon D D, Crulchlow M F, Ham J Y, et al.Role of glucagon - like peptide - 1 in the pathogenesis and treatment of diabetes mellitus. Int J Biochem Cell Biol, 2006, 38(5~ 6): 845.
  • 4王秀贞,吴军,孟宪军.长效多肽药物研究进展[J].中国生物工程杂志,2003,23(10):23-27. 被引量:6
  • 5Chamow S M, Duliege A M, Ammann A, et al. CD4 immunoadhesinsin anti -HIVtherapy:New developments, Int J Cancer, 1992, 7: 69.
  • 6Tanaka T,Shiramoto S, Miyashita M, et al. Tumor targeting based on the effect of enhanced permeability and retention (EPR) and the mechanism of receptor mediated endocytosis (RME).International Journal of Pharmaceutics,2004,277:39-61.
  • 7BalanceDJ.重组人生长激素和人血清白蛋白融合蛋白[P].CN1207131.1999.
  • 8Goodey A R. The production of heterologousplasmaproteins. Trends Biotechnol, 1993, 11(10): 430-433.
  • 9Yeh P, Landais D, Lemaitre M, et al. Design of yeast-secreted albumin derivatives for human therapy: biological and antiviral properties of a serum albumin-CD4 genetic conjugate. Proc Natl Acad Sci USA, 1992, 89 (5): 1904- 1908.
  • 10Osborn B L, Olsen H S, Nardelli B, et al. Pharmacokinetic and pharmacodynamic studies of a human serum albumin-interferon-alpha fusion protein in cynomolgus monkeys. J Pharmacol Exp Ther, 2002, 303 (2): 540- 548.

二级参考文献170

  • 1凌焱,段海清,陈惠鹏.合成生物学[J].军事医学科学院院刊,2006,30(6):572-574. 被引量:13
  • 2马清均主编.生物技术药物[M].北京:化学工业出版社,2002.50-51.
  • 3Hobom B. Gene surgery: on the threshold of synthetic biology. Med Klin, 1980, 75(24): 834-41.
  • 4Cello J, Paul AV, Wimmer E. Chemical synthesis of poliovirus cDNA: generation or infectious virus in the absence of natural template. Science, 2002, 297(5583): 1016-8.
  • 5Chan LY, Kosuri S, Endy D. Refactoring bacteriophage T7. Mol Syst Biol, 2005, 1:2005.0018.
  • 6Posfai G, Plunkett G, Feher T, et al. Emergent properties of reduced-genome Escherichia coli. Science, 2006, 312(5776): 1044-6.
  • 7Gibson DG, Benders GA, Andrews-Pfannkoch C, et al. Complete chemical synthesis, assembly, and cloning of a Mycoplasma genitalium genome. Science, 2008, 319(5867): 1215-20.
  • 8Gibson DG, Glass JI, Lartigue C, et al. Creation of a bacterial cell controlled by a chemically synthesized genome. Science, 2010, 329(5987): 52-6.
  • 9Gardner TS, Cantor CR, Collins JJ. Construction of a genetic toggle switch in Escherichia coli. Nature, 2000, 403(6767): 339-42.
  • 10Isaacs F J, Dwyer D J, Collins JJ. RNA synthetic biology. Nat Biotechnol, 2006, 24:545-54.

共引文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部